Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Publication year range
1.
Sci Rep ; 12(1): 14576, 2022 08 26.
Article in English | MEDLINE | ID: mdl-36028747

ABSTRACT

PERM1 (PGC-1/ERR-induced regulator in muscle 1) is a muscle-specific protein induced by PGC-1 and ERRs. Previous studies have shown that PERM1 promotes mitochondrial biogenesis and metabolism in cardiomyocytes in vitro. However, the role of endogenous PERM1 in the heart remains to be investigated with loss-of-function studies in vivo. We report the generation and characterization of systemic Perm1 knockout (KO) mice. The baseline cardiac phenotype of the homozygous Perm1 KO mice appeared normal. However, RNA-sequencing and unbiased pathway analyses showed that homozygous downregulation of PERM1 leads to downregulation of genes involved in fatty acid and carbohydrate metabolism in the heart. Transcription factor binding site analyses suggested that PPARα and PGC-1α are involved in changes in the gene expression profile. Chromatin immunoprecipitation assays showed that PERM1 interacts with the proximal regions of PPAR response elements (PPREs) in endogenous promoters of genes involved in fatty acid oxidation. Co-immunoprecipitation and reporter gene assays showed that PERM1 promoted transcription via the PPRE, partly in a PPARα and PGC-1α dependent manner. These results suggest that endogenous PERM1 is involved in the transcription of genes involved in fatty acid oxidation through physical interaction with PPARα and PGC-1α in the heart in vivo.


Subject(s)
Lipid Metabolism , Muscle Proteins , PPAR alpha , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha , Animals , Fatty Acids , Mice , Mice, Knockout , Muscle Proteins/metabolism , Myocytes, Cardiac , PPAR alpha/metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/metabolism
2.
Nutrients ; 8(12)2016 Dec 12.
Article in English | MEDLINE | ID: mdl-27973445

ABSTRACT

We previously reported that bitter melon seed oil (BMSO) was an effective anti-steatosis and antiobesity agent. Since the major fatty acid α-eleostearic acid (α-ESA) in BMSO is a peroxisome proliferator-activated receptor α (PPARα) activator, the objective was to investigate the role of PPARα in BMSO-modulated lipid disorders and α-ESA metabolism. C57BL/6J wild (WD) and PPARα knockout (KO) mice were fed a high-fat diet containing BMSO (15% soybean oil + 15% BMSO, HB) or not (30% soybean oil, HS) for 5 weeks. The HB diet significantly reduced hepatic triglyceride concentrations and increased acyl-CoA oxidase activity in WD, but not in KO mice. However, regardless of genotype, body fat percentage was lowered along with upregulated protein levels of uncoupling protein 1 (UCP1) and tyrosine hydroxylase, as well as signaling pathway of cAMP-dependent protein kinase and AMP-activated protein kinase in the white adipose tissue of HB-treated groups compared to HS cohorts. In WD-HB and KO-HB groups, white adipose tissue had autophagy, apoptosis, inflammation, and browning characteristics. Without PPARα, in vivo reduction of α-ESA into rumenic acid was slightly but significantly lowered, along with remarkable reduction of hepatic retinol saturase (RetSat) expression. We concluded that BMSO-mediated anti-steatosis depended on PPARα, whereas the anti-adiposity effect was PPARα-independent. In addition, PPARα-dependent enzymes may participate in α-ESA conversion, but only have a minor role.


Subject(s)
Dyslipidemias/drug therapy , Linoleic Acids, Conjugated/metabolism , Linolenic Acids/metabolism , Momordica charantia/chemistry , PPAR alpha/physiology , Phytotherapy , Plant Oils/chemistry , Acyl-CoA Oxidase/metabolism , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Adiposity/drug effects , Animals , Cyclic AMP-Dependent Protein Kinases/metabolism , Diet, High-Fat/adverse effects , Dyslipidemias/metabolism , Fatty Liver/drug therapy , Liver/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxidoreductases Acting on CH-CH Group Donors/metabolism , PPAR alpha/genetics , PPAR alpha/metabolism , Plant Oils/administration & dosage , Signal Transduction/drug effects , Triglycerides/metabolism , Tyrosine 3-Monooxygenase/metabolism , Uncoupling Protein 1/metabolism
3.
Mater Sci Eng C Mater Biol Appl ; 49: 7-13, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25686921

ABSTRACT

Well-designed implants are used not only to modify the geometry of the implant but also to change the chemical properties of its surfaces. The present study aims to assess the biofunctional effects of tetracalcium phosphate (TTCP) particles as a physical anchor on the implant surface derived through sandblasting. The characteristics of the surface, cell viability, and alkaline phosphatase (ALP) activity toward osteoprogenitor cells (D1) were obtained. D1 cells were cultured on a plain surface that underwent sandblasting and acid etching (SLA) (control SLA group) and on different SLA surfaces with different anchoring TTCP rates (new test groups, M and H). The mean anchoring rates were 57% (M) and 74% (H), and the anchored thickness was estimated to range from 12.6µm to 18.3µm. Compared with the control SLA surface on Ti substrate, the new test groups with different TTCP anchoring rates (M and H) failed to improve cell proliferation significantly but had a well-differentiated D1 cell phenotype that enhanced ALP expression in the early stage of cell cultures, specifically, at day 7. Results suggest that the SLA surface with anchored TTCP can accelerate progenitor bone cell mineralization. This study shows the potential clinical application of the constructed geometry in TTCP anchorage on Ti for dental implant surface modification.


Subject(s)
Calcium Phosphates , Osteoblasts/cytology , Stem Cells/cytology , Titanium , Animals , Mice , NIH 3T3 Cells , Surface Properties , X-Ray Diffraction
4.
Nutrition ; 31(5): 691-6, 2015 May.
Article in English | MEDLINE | ID: mdl-25837214

ABSTRACT

OBJECTIVES: Lycopene is a carotene and phytochemical known to protect against metabolic diseases. It is found in red fruits and vegetables, predominantly tomatoes. This study aimed to show the supplementation effect of tomato juice on indices associated with metabolic health and adipokine profiles in generally healthy people. METHODS: A total of 30 young females (20- to 30-years-old) with a body mass index (BMI) ≥ 20 were recruited, of whom 25 completed the entire study. The subjects continued with their normal diet and exercise schedule, but were given 280 mL of tomato juice (containing 32.5 mg of lycopene) daily for 2 mo. Metabolic indices, including anthropometric data and serum levels of glucose, lipids, adipokines, lycopene, and antioxidants, were compared pre- and postintervention. RESULTS: Tomato juice supplementation significantly reduced body weight, body fat, waist circumference, BMI, and serum levels of cholesterol, monocyte chemoattractant protein-1 (MCP-1), and thiobarbituric reactive substances, while significantly increasing serum levels of adiponectin, triglyceride, and lycopene. When subjects were stratified by body fat change, i.e., reduction or non-reduction (including increase or no change), the tomato juice-induced reduction in waist circumference, serum cholesterol, and MCP-1 levels and increase in adiponectin and lycopene levels were seen in both subgroups. The changes in waist circumference, cholesterol, MCP-1, and adiponectin levels remained significant after adjusting for each covariable individually, with the exception of lycopene. CONCLUSIONS: These results show that daily tomato juice supplementation reduces waist circumference, as well as serum cholesterol and inflammatory adipokine levels in young healthy women and that these effects are unrelated to body fat changes.


Subject(s)
Adipokines/blood , Carotenoids/pharmacology , Chemokine CCL2/blood , Cholesterol/blood , Inflammation/diet therapy , Solanum lycopersicum/chemistry , Waist Circumference/drug effects , Adiponectin/blood , Adipose Tissue/drug effects , Adult , Anthropometry/methods , Antioxidants/analysis , Blood Glucose/drug effects , Body Mass Index , Body Weight/drug effects , Carotenoids/administration & dosage , Carotenoids/blood , Dietary Supplements , Female , Fruit and Vegetable Juices , Humans , Inflammation/blood , Lipids/blood , Lycopene , Thiobarbituric Acid Reactive Substances/analysis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL